(2R,3S,4S,5R,6S)-2-(羟甲基)-6-(4-((E)-3-羟基丙-1-烯-1-基)-2,6-二甲氧基苯氧基)四氢-2H-吡喃-3,4,5-三醇
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol
| 产品编号.: | A118343 | CAS号: | 118-34-3 |
| 分子式: | C17H24O9 | 分子量: | 372.3671 |
| 纯度: | 98% | MDL NO.: |
中文名称：(2R,3S,4S,5R,6S)-2-(羟甲基)-6-(4-((E)-3-羟基丙-1-烯-1-基)-2,6-二甲氧基苯氧基)四氢-2H-吡喃-3,4,5-三醇
CAS号：118-34-3
中文别名：(2R,3S,4S,5R,6S)-2-(羟甲基)-6-(4-((E)-3-羟基丙-1-烯-1-基)-2,6-二甲氧基苯氧基)四氢-2H-吡喃-3,4,5-三醇
英文名称：(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol
英文别名：(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol "" ];Syrigin;Syringenin;4-[(1E)-3-hydroxyprop-1-en-1-yl]-2,6-dimethoxyphenyl beta-D-glucopyranoside;I6F5B11C96;Ligustrin (VAN);.beta.-Terpineol;C17H24O9;Magmolenin A;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxypro;Eleutheroside B;Syringin;NSC 287441;ELEUTHEROSIDE B [USP-RS];beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl;Methoxyconiferin;NSC287441;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol;C01533;CHEMBL250872;HMS2217D04;SMR000156227;ELEUTHEROSIDE B (CONSTITUENT OF ELEUTHERO);Eleutheroside B, analytical standard;DTXCID0022438;UNII-I6F5B11C96;Syringinenin;4-((1E)-3-HYDROXY-1-PROPEN-1-YL)-2,6-DIMETHOXYPHENYL-beta-D-GLUCOPYRANOSIDE;MEGxp0_000264;BDBM50241356;4-((1E)-3-HYDROXY-1-PROPEN-1-YL)-2,6-DIMETHOXYPHENYL-.BETA.-D-GLUCOPYRANOSIDE;Q891785;SYRINGIN [MI];MLS000574917;eleutheroside-b;4-O-(beta-D-glucosyl)-trans-4-sinapyl alcohol;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol;(2S,3R,4S,5S,6R)-2-[2,6-dimethoxy-4-[(E)-3-oxidanylprop-1-enyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol;s3841;AKOS015912605;NSC-287441;2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol;A803915;.beta.-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxy-phenoxy]tetrahydropyran-3,4,5-triol;HY-N0824;MAGNOLENIN A;4-((1E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenyl beta-D-glucopyranoside;118-34-3;Eleutheroside B, United States Pharmacopeia (USP) Reference Standard;NSC-791584;ACon1_000108;Syringoside;MFCD00016778;I(2)-D-Glucopyranoside, 4-[(1E)-3-hydroxy-1-propen-1-yl]-2,6-dimethoxyphenyl;4-O-(beta-D-glucosyl)-trans-4-sinapoyl alcohol;CCG-268321;Syringin,(S);beta-D-Glucopyranoside, 4-((1E)-3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl;Q-100086;CS-0009856;ELEUTHEROSIDE B (CONSTITUENT OF ELEUTHERO) [DSC];(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-enyl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol;SCHEMBL409032;DTXSID2042438;CHEBI:9380;NCGC00180873-01;Glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, D;ELEUTHEROSIDE B (USP-RS);NS00023810;Ligustrin;bmse000613;HMS3885E08;NSC791584;sinapyl alcohol-4-O-beta-D-g...
EINECS:287441
分子式：C17H24O9
分子量：372.3671
CAS号：118-34-3
中文别名：(2R,3S,4S,5R,6S)-2-(羟甲基)-6-(4-((E)-3-羟基丙-1-烯-1-基)-2,6-二甲氧基苯氧基)四氢-2H-吡喃-3,4,5-三醇
英文名称：(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol
英文别名：(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol "" ];Syrigin;Syringenin;4-[(1E)-3-hydroxyprop-1-en-1-yl]-2,6-dimethoxyphenyl beta-D-glucopyranoside;I6F5B11C96;Ligustrin (VAN);.beta.-Terpineol;C17H24O9;Magmolenin A;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxypro;Eleutheroside B;Syringin;NSC 287441;ELEUTHEROSIDE B [USP-RS];beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl;Methoxyconiferin;NSC287441;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol;C01533;CHEMBL250872;HMS2217D04;SMR000156227;ELEUTHEROSIDE B (CONSTITUENT OF ELEUTHERO);Eleutheroside B, analytical standard;DTXCID0022438;UNII-I6F5B11C96;Syringinenin;4-((1E)-3-HYDROXY-1-PROPEN-1-YL)-2,6-DIMETHOXYPHENYL-beta-D-GLUCOPYRANOSIDE;MEGxp0_000264;BDBM50241356;4-((1E)-3-HYDROXY-1-PROPEN-1-YL)-2,6-DIMETHOXYPHENYL-.BETA.-D-GLUCOPYRANOSIDE;Q891785;SYRINGIN [MI];MLS000574917;eleutheroside-b;4-O-(beta-D-glucosyl)-trans-4-sinapyl alcohol;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol;(2S,3R,4S,5S,6R)-2-[2,6-dimethoxy-4-[(E)-3-oxidanylprop-1-enyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol;s3841;AKOS015912605;NSC-287441;2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol;A803915;.beta.-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxy-phenoxy]tetrahydropyran-3,4,5-triol;HY-N0824;MAGNOLENIN A;4-((1E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenyl beta-D-glucopyranoside;118-34-3;Eleutheroside B, United States Pharmacopeia (USP) Reference Standard;NSC-791584;ACon1_000108;Syringoside;MFCD00016778;I(2)-D-Glucopyranoside, 4-[(1E)-3-hydroxy-1-propen-1-yl]-2,6-dimethoxyphenyl;4-O-(beta-D-glucosyl)-trans-4-sinapoyl alcohol;CCG-268321;Syringin,(S);beta-D-Glucopyranoside, 4-((1E)-3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl;Q-100086;CS-0009856;ELEUTHEROSIDE B (CONSTITUENT OF ELEUTHERO) [DSC];(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-enyl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol;SCHEMBL409032;DTXSID2042438;CHEBI:9380;NCGC00180873-01;Glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, D;ELEUTHEROSIDE B (USP-RS);NS00023810;Ligustrin;bmse000613;HMS3885E08;NSC791584;sinapyl alcohol-4-O-beta-D-g...
EINECS:287441
分子式：C17H24O9
分子量：372.3671
搜索质检报告(COA)
搜索MSDS
